A case-control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing titre of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) latent nuclear antigens, independently of HIV infection. Clinically, widespread Kaposi's sarcoma was more frequent among patients with HIV infection than in those without, but was not related to anti-KSHV antibody titres
The association between the prevalence of antibodies against Kaposi's sarcoma-associated herpesvirus...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
The association between the prevalence of antibodies against Kaposi's sarcoma-associated herpesvirus...
A case-control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing t...
A case-control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing t...
A case-control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing t...
As part of a larger investigation of cancer in Uganda, we conducted a case-control study of Kaposi's...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
As part of a larger investigation of cancer in Uganda, we conducted a case-control study of Kaposi's...
Over the past two decades there has been an explosion in the number of cases of Kaposi’s sarcoma (KS...
BACKGROUND: Endemic Kaposi's sarcoma (KS) is a clinically and epidemiologically distinct human immun...
BACKGROUND: Kaposi's sarcoma (KS) is associated epidemiologically with HIV infection and with human ...
BACKGROUND: Kaposi's sarcoma (KS) is associated epidemiologically with HIV infection and with human ...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
With the advent of AIDS, Kaposi’s sarcoma (KS) has become one of the leading malignancies in sub-Sah...
The association between the prevalence of antibodies against Kaposi's sarcoma-associated herpesvirus...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
The association between the prevalence of antibodies against Kaposi's sarcoma-associated herpesvirus...
A case-control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing t...
A case-control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing t...
A case-control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing t...
As part of a larger investigation of cancer in Uganda, we conducted a case-control study of Kaposi's...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
As part of a larger investigation of cancer in Uganda, we conducted a case-control study of Kaposi's...
Over the past two decades there has been an explosion in the number of cases of Kaposi’s sarcoma (KS...
BACKGROUND: Endemic Kaposi's sarcoma (KS) is a clinically and epidemiologically distinct human immun...
BACKGROUND: Kaposi's sarcoma (KS) is associated epidemiologically with HIV infection and with human ...
BACKGROUND: Kaposi's sarcoma (KS) is associated epidemiologically with HIV infection and with human ...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
With the advent of AIDS, Kaposi’s sarcoma (KS) has become one of the leading malignancies in sub-Sah...
The association between the prevalence of antibodies against Kaposi's sarcoma-associated herpesvirus...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
The association between the prevalence of antibodies against Kaposi's sarcoma-associated herpesvirus...
Add to ORKG